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Abstract
Aloe products are one of the top selling health-functional foods in Korea, however the adequate level of intake to achieve desirable effects are
not well understood. The objective of this study was to determine the intestinal uptake and metabolism of physiologically active aloe components
using in vitro intestinal absorption model. The Caco-2 cell monolayer and the everted gut sac were incubated with 5-50 μM of aloin, aloe-emodin, 
and aloesin. The basolateral appearance of test compounds and their glucuronosyl or sulfated forms were quantified using HPLC. The % absorption
of aloin, aloe-emodin, and aloesin was ranged from 5.51% to 6.60%, 6.60% to 11.32%, and 7.61% to 13.64%, respectively. Up to 18.15%, 18.18%, 
and 38.86% of aloin, aloe-emodin, and aloesin, respectively, was absorbed as glucuronidated or sulfated form. These results suggest that a significant
amount is transformed during absorption. The absorption rate of test compounds except aloesin was similar in two models; more aloesin was absorbed
in the everted gut sac than in the Caco-2 monolayer. These results provide information to establish adequate intake level of aloe supplements to
maintain effective plasma level.



















Fig. 1. Chemical structures of aloin, aloe-emodin and aloesin
Introduction2)
Aloe is widely used in food products, pharmaceuticals, and 
cosmetics due to its aromatic and therapeutic properties (Davis 
et al., 1994; Korkina et al., 2003). The aloe product ranked first 
in health food sales of 2005 in Korea (Park et al., 2005). Aloe 
leaves consist of gel and latex. Most of the compounds in leaf 
exudate identified so far are chromones, anthraquinones and 
anthrones. Aloin is the major anthraquinone of aloe and 
characterized as the C-glycoside of aloe-emodin (Fig. 1) (Saccù 
et al., 2001). Aloesin is a chromone derivative isolated from aloe, 
which is regarded as the parent compound of the aloe chromones 
(McCarthy & Haynes, 1967). 
Due to their polyphenolic structure, aloin, aloe-emodin and 
aloesin are considered as physiologically active components 
responsible for reported biological effects such as reduction of 
inflammation (Speranza et al., 2005), acceleration of wound 
healing (Maenthaisong et al., 2007; Moore & Cowman, 2008; 
Ni  et al., 2007), and protective effect against liver injury 
(Chandan  et al., 2007). 
However, the ingestion of aloe is known to be associated with 
diarrhea (Ishii et al., 1994) and possible cell cytotoxicity (Esmat 
et al., 2006). Although the mechanisms that control the balance 
of these various effects are poorly known, the information on 
bioavailability of aloe components will provide new insight into 
a proper amount of oral intake to exert expected in vivo 
physiological activity. Therefore, we measured intestinal % 
absorption and transformation of major aloe components using 
two types of in vitro intestinal absorption model. 
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Materials and Methods
Chemicals and reagents 
Aloin and aloe-emodin were purchased from the Sigma-Aldrich 
Co. (St. Louis, MO, USA) and aloesin was supplied by Univera 
Inc. (Seoul, Korea). Dulbecco’s modified Eagle medium (DMEM), 
fetal bovine serum (FBS), sodium pyruvate, L-glutamine, 
antibiotics-antimycotics solution, and trypsin-EDTA were 
purchased from GIBCO Co. (Grand Island, NY, USA). HPLC 
grade methanol and water were from Merck (Darmstadt, Germany). 
Other chemicals otherwise indicated were from Sigma-Aldrich 
Co. (St. Louis, MO, USA). 
Cell culture
Caco-2 cells were obtained from American Type Culture 
Collection (ATCC, Rockville, MD, USA). The cells were 
cultured in DMEM media with high glucose and L-glutamine, 
supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml 
streptomycin, and 1% nonessential amino acids. The atmosphere 
was kept with 90-95% relative humidity, 37℃, 5% CO2, and 
95% air.
Preparation of Caco-2 differentiated monolayer 
For the uptake studies, Caco-2 cells were seeded on Transwell 
insert (12-well, Corning Costar Corp., Cambridge, MA, USA) 
at density of 5×10
4  cells/cm
2. The cells were used between 
passages number 26-48. The cell medium was replaced every 
other day for 18-24 days until analysis. The integrity of the cell 
monolayer was confirmed by the transepithelial electric resistance 
(TEER) values measured using a Millicell-ERS voltohmmeter 
(Millipore Corp., USA). The monolayer with TEER of more than 
550  Ω∙cm
2 was used for the uptake experiments.
Uptake experiments
To measure the apical-to-basolateral uptake, 1.5 ml of HBSS 
(pH 7.4, 37℃) was added to the basolateral chamber of the 
Transwell insert and then 0.5 ml of the test solution (pH 6.0, 
37℃) containing aloe components (aloin, aloe-emodin, or 
aloesin) was added to the apical side. Aloin, aloe-emodin, or 
aloesin was dissolved in dimethyl sulfoxide (DMSO) and diluted 
with HBSS prior to starting the experiment. The final 
concentrations of each compound were 5, 10, and 50 μM. These 
test solutions were added on the apical side of Caco-2 monolayers 
and incubated for 1 hr at 37℃. After the incubation, the apical 
and the basolateral solutions were collected and stored at -70℃ 
until assayed. The % absorption of aloe components was 
calculated as (basolateral side concentration of aloe components 
after incubation × 100) / (apical side treatment concentration of 
aloe components).
Everted gut sac model
After an overnight fast, the rats were sacrificed by a qualified 
person, and the entire small intestine was quickly excised and 
flushed through several times with NaCl solution (0.9%, w/v) 
at room temperature and immediately placed in warm (37℃), 
oxygenated TC 199 medium. The intestine was gently everted 
over a glass rod (2.5 mm diameter), and one end was clamped 
and the whole length of the intestine was filled with fresh 
oxygenated medium and sealed with a second clamp and the 
resulting large gut sac was divided into sacs of around 2.5 cm 
in length using braided silk sutures. For each experiment, 12-15 
sacs were prepared, starting from the end of the duodenum, to 
ensure that sacs were from the upper/mid-jejunum where 
transport activity is maximal. To study tissue uptake of aloin, 
aloe-emodin or aloesin, 10 μM test compounds were added to 
the chambers. The sacs were then placed in individual incubation 
chambers containing 6 ml of pre-gassed oxygenated media at 
37℃. At one hour incubation, sacs were removed, washed three 
times in saline (0.9%, w/v) and blotted dry, cut open and the 
serosal fluid drained into small tubes. Each sac was weighed 
before and after serosal fluid collection to calculate the volume 
inside the sac. The protein content of the digest or homogenates 
was determined using the modified Lowry method (Keller & 
Neville, 1986) with bovine serum albumin as standard and the 
uptake into the serosal side was expressed as nmol/mg of tissue 
protein.
Sample preparation for HPLC analysis 
The apical and the basolatral solutions and the serosal and the 
mucosal fluids were each divided into two aliquots. Half of either 
apical or basolateral solution
  was mixed with 20 U of a sulfatase 
type
  H-5 solution in 100 mmol/L acetate buffer (0.1 mL, pH 
5.0) and
  incubated at 37℃ for 45 min. Then, the same volume 
of methanol
  was added to the mixture and centrifuged at 10,000 ×
g for 10
  min. The resulting supernatant solution was used as 
a sulfatase-treated
  sample. The other half was dissolved and used 
as an untreated
  sample. The amounts of the metabolites 
(glucuronides/sulfates)
  were calculated by the difference between 
the amounts of aloin/aloe-emodin/aloesin
  from sulfatase-treated 
samples and those from untreated samples. Because sulfatase type 
H-5 possesses
  sulfatase, glucuronidase, and glucosidase activities, 
other
  metabolized forms, such as methylated forms, were not 
identified
  in this study.
HPLC analysis 
Aloin, aloe-emodin, and aloesin were identified by HPLC 
analysis using a C18 column (150 × 4.6 mm i.d.; 5 μm). The 
mobile phase at a flow rate of 1.0 ml/min was composed of 
acetonitrile/water (80:20, v/v) for aloin, and methanol/water 
(80:20, v/v) for aloesin. The eluate was monitored with a UV Mi-Young Park et al. 11
Table 1. Concnetration of aloin and its glucuronides/sulfates in basolateral side
of Caco-2 monolayer model
Treatment 
(μM)






50 . 1 1 ± 0 . 1 6
c 0.05 ± 0.15
b
10 0.42 ± 0.15
b 0.11 ± 0.11
b
50 1.99 ± 0.10
a 0.62 ± 0.12
a
Values  are  means ± S.D. 
Means with letters (a, b, c) within a column are significantly different from each other 
at  p<0.05  as  determined  by  Duncan’s  multiple  range  test.
Table 2. Concnetration of aloe-emodin and its glucuronides/sulfates in 
basolateral side of Caco-2 monolayer model 
Treatment 
(μM)






50 . 1 3 ± 0 . 1 1
c 0.06 ± 0.12
b
10 0.86 ± 0.13
b 0.12 ± 0.09
b
50 2.51 ± 0.08
a 0.92 ± 0.06
a
Values  are  means ± S.D. 
Means with letters (a, b, c) within a column are significantly different from each other 
at  p<0.05  as  determined  by  Duncan’s  multiple  range  test.
Table 3. Concnetration of aloesin and its glucuronides/sulfates in basolateral
side of Caco-2 monolayer model 
Treatment 
(μM)
Conc. of aloesin 
(nmol/cm
2 culture area)
Conc. of glucuronides/sulfates 
(nmol/cm
2 culture area)
5 0.03 ± 0.13
b 0.12 ± 0.09
c
10 0.26 ± 0.17
b 0.53 ± 0.11
b
50 1.22 ± 0.11
a 2.54 ± 0.09
a
Values  are  means ± S.D. 
Means with letters (a, b, c) within a column are significantly different from each other 
at  p<0.05  as  determined  by  Duncan’s  multiple  range  test.






55 . 5 1 ± 0 . 3 9
b  6.60 ± 0.53
b  7.61 ± 0.59
b
10 6.60 ± 0.28
a 11.32 ± 0.54
a 13.64 ± 1.40
a
50 5.92 ± 0.50
ab  7.81 ± 0.44
ab  8.14 ± 0.79
b
Values  are  means ± S.D. 
Means with letters (a, b) within a column are significantly different from each other 
at  p<0.05  as  determined  by  Duncan’s  multiple  range  test.
detector at 254 nm. For the analysis of aloe-emodin, HPLC was 
performed using a TSP system (Thermo Quest, Tokyo, Japan) 
equipped with two P4000 gradient pumps, a UV 6000 photodiode 
array detector (200-500 nm range; 5 nm bandwidth) and an LCQ 
ESI/MS detector controlled by Chromoquest software (version 
2.51; 1998). 
Statistical analysis
All the data from the experiment were expressed as mean ± 
S.D. Data were analyzed by one-way analysis of variance 
(ANOVA) followed by Duncan’s multiple range test. Differences 
were considered statistically significant at p<0.05. 
Results
Absorption of aloin in Caco-2 cell model 
Aloin applied to the apical side of Caco-2 monolayer at a 
concentration range between 5-50 μM increased aloin and its 
glucuronated or sulfated forms at basolateral side (Table 1). Aloin 
concentration was 0.11, 0.42, and 1.99 nmol/cm
2 culture area 
and its metabolized conjugates concentration was 0.05, 0.11, and 
0.62 nmol/cm
2 culture area when 5, 10, and 50 μM of aloin 
was applied, respectively. The results imply that a significant 
amount of aloin is converted by phase II enzyme present in the 
epithelial cells.
Absorption of aloe-emodin in Caco-2 cell model 
Aloe-emodin, the aloin aglycon, was applied to the apical side 
of Caco-2 monolayers at 5-50 μM, and not only aloe-emodin 
but its glucuronides/sulfates were detected in the basolateral side 
solution after 1 hour incubation (Table 2). Aloe-emodin 
concentration was 0.13, 0.86, and 2.51 nmol/cm
2 culture area 
and its metabolized conjugates concentration was 0.06, 0.12, and 
0.92 nmol/cm
2 culture area when cells were treated with 5, 10, 
and 50 μM, respectively. The absorption rate of aloe-emodin was 
higher than that of aloin. There was a dose-dependent increase 
in absorption rate. The absorption rate of 50 μM aloe-emodin, 
however, was lower than that of 10 μM aloe-emodin, indicating 
that aloe-emodin may start to approach to physiological 
saturation levels at 50 μM treatment.
Absorption of aloesin in Caco-2 cell model
Aloesin, a chromone aglycon applied to the apical side of 
Caco-2 monolayers at 5-50 μM of concentration was appeared 
as aloesin and its glucuronides/sulfates forms in the basolateral 
side solution after 1 hour incubation (Table 3). Unlike aloin or 
aloe-emodin, the amount of glucuronides/sulfates forms was 
higher than that of aglycon, suggesting that phase II enzymes 
may play an important role in the aloesin absorption. The % 
absorption of aloesin was 7.61%, 13.64%, and 8.14% at 5, 10, 
and 50 μM, respectively, which were higher than those of either 
aloin or aloe-emodin (Table 4). Aloesin showed a similar 
absorption pattern with aloe-emodin.
Absorption of aloin, aloe-emodin, and aloesin in everted gut sac 
model 
To compare the Caco-2 monolayer with the everted gut sac 
as an in vitro model of intestinal absorption, everted gut sacs 
were incubated with aloin, aloe-emodin, and aloesin at 10 μM 
concentration. As shown in Table 5, both aloe components and 
their glucuronide/sulfate forms were also detected in the everted 
gut sac model. The levels of aloin and aloe-emodin were higher 12 Intestinal absorption of aloe components
Table 5. Concentration of aloe components and their glucuronides/sulfates in
serosal side of everted gut sac model 
Treatment 
(10  μM)
Conc. of original forms 
(nmol/mg of tissue protein)
Conc. of glucuronides/sulfates 
(nmol/mg of tissue protein)
Aloin 0.45 ± 0.12
b 0.13 ± 0.09
b
A-emodin 0.91 ± 0.16
a 0.14 ± 0.11
b
Aloesin 0.53 ± 0.11
b 1.42 ± 0.15
a
Values  are  means ± S.D. 
Means with letters (a, b,c) within a column are significantly different from each other 
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Fig. 2. Percent absorptions of aloe components in Caco-2 monolayer model 
and everted gut sac model. To measure the absorption in everted gut sac model, 
aloin, aloe-emodin, or aloesin solutions (10 μM) were incubated with everted gut 
sac for 1 hr at 37℃. After the incubation, the solutions in the sacs were assayed 
by HPLC. The amounts of the glucuronides/sulfates conjugates were calculated by 
the  difference  between  the  amounts  of  aloin,  aloe-emodin,  or  aloesin  from 
sulfatase-treated samples and those from untreated samples. Values are means ±
S.D. Means with letters (a, b, c) within a column are significantly different from each 
other at p<0.05 as determined by Duncan’s multiple range test. Means with # is 
significantly  different  from  corresponding  everted  gut  sac,  #<0.01. 
than their metabolized conjugates, whereas the level of aloesin 
was less than its metabolized conjugates in the sac (Table 5). 
The % absorption of both aloin and aloe-emodin was similar 
to the Caco-2 monolayer data, while more aloesin were shown 
to be absorbed in the gut sac compared to the Caco-2 monolayer 
(p<0.05) (Fig. 2).
Discussion
In this study, we determined the absorption rate and absorption 
forms of aloin, aloe-emodin, and aloesin using the Caco-2 cell 
monolayer model and the everted gut sac model. Despite the 
frequent use of aloe and its products, limited information is 
available for their bioavailability which is a very common 
phenomenon for other phytochmicals as well. 
Caco-2 cells are derived from the human colon carcinoma, 
however, they spontaneously differentiate into the absorptive 
intestine-like cells during culture, such as microvillous structure, 
carrier-mediated transport system, and brush-border enzyme 
(Hidalgo  et al., 1989). These features of Caco-2 cell line are 
similar to those of the small intestine rather than the colon. Due 
to its similarity to human intestinal epithelium, Caco-2 cell 
culture model has been widely used to determine the absorption 
rate of chemicals in food or drug. The everted gut sac is also 
a useful in vitro model to study drug transport (Barthe et al., 
1999) and provides information on absorption mechanisms. It 
mimics  in vivo intestinal environment, however needs to be 
carefully prepared from rat small intestine for good morphology. 
The everted gut sac is metabolically active only for 2 h at 37℃.
In this study, the % absorption of aloin, aloe-emodin, and 
aloesin was ranged from 5.51% to 6.60%, 6.60% to 11.32%, 
and 7.61% to 13.64%, respectively, between 5 μM and 50 μM. 
The mechanisms and characteristics of intestinal anthraquinone 
absorption are not well understood compared to other polyphenols. 
Alves et al. (2004) reported that emodin showed a higher affinity 
for phospholipid membranes than aloin did. Affinity to the 
cellular membrane plays an important role in the efficiency of 
cellular uptake by passive diffusion. Azuma et al. (2002) showed 
that a combination of lipids and emulsifiers is necessary for 
enhancing quercetin absorption. Thus the lower concentration in 
basolateral solution probably resulted from the poor lipophilic 
properties of aloin. The initial step in the absorption process for 
polyphenols is deglycosylation. Previous studies (Lambert et al., 
1999; Németh et al., 2003; Wilkinson et al., 2003) found specific 
intracellular and membrane-bound hydrolyzing enzyme activity 
in the small intestine is a critical determinant in polyphenol 
absorption process. This might explain the difference in cellular 
absorption efficiency between aloin and aloe-emodin. 
An alternative absorptive mechanism involves transport of the 
polyphenol glycoside into the enterocyte as an intact form via 
the function of a sugar transporter such as sodium-dependent 
glucose transporter-1 (SGLT1) (Olthof et al., 2000). Sodium- 
dependent efflux of pre-loaded radio-labeled galactose by rat 
everted jejunum sacs provided evidence that the SGLT-1 interacts 
with flavonoid glycosides including quercetin-3-glucoside 
(Q3Glc) and quercetin-4’-glucoside (Q4’Glc) (Gee et al., 1998). 
During absorption, polyphenols are metabolized in the Caco-2 
cells by a phase II metabolic enzyme such as glucuronyl-, 
sulfate-, or glutathione-transferase, each of which may play an 
important role in drug accumulation and transport in human 
intestine (Vereczkey et al., 2005). Our results suggest that a 
significant proportion of aloin and aloe-emodin was converted 
to their glucuronide/sulfate conjugates during absorption. 
Mailleau et al. (1998) reported that SGLT1 activity was rapidly 
increased from day 12 up to day 20 post-seeding of Caco-2 cells. 
Studies also reported that monoglucosides of polyphenols can 
be transported across the apical membrane of enterocytes by the 
SGLT1 (Gee et al., 1998; Walgren et al., 2000). The absorption 
of aloin in its unchanged form in this study may indicate the 
involvement of the SGLT1, since aloin shares a basic monoglucoside 
structure. The lower % absorption of aloin compared to aloe- 
emodin may be explained by a limited number of receptors/ 
transporters capable of handling the molecule. In a recent study, 
Teng et al. (2007) reported that the SGLT1 blocker can inhibit 
the cellular accumulation of emodin across the apical membrane 
of Caco-2 cells. This suggests that partial intestinal absorption 
of emodin may be transported by SGLT1. These results indicate Mi-Young Park et al. 13
that the absorption of aloe-emodin, crossing the apical membrane 
in Caco-2 cells, may be partially influenced by SGLT1 and be 
metabolized by phase II enzymes. 
We observed that the absorption rate of aloe-emodin was 
significantly higher at 10 μM treatment compare to those of the 
5 μM or 50 μM treatment, indicating that aloe-emodin may start 
to approach to physiological saturation level at 50 μM treatment.
Chromones form a class of compounds, the importance of 
which arises from their wide natural occurrence as subunits in 
flavonoids (Miao & Yang, 2000) and their biological activities 
(Hadjeri  et al., 2003). However, reports on the metabolism or 
absorption properties of chromones are limited (Kanai et al., 
1979; Maurizis et al., 1991; Muni et al., 1978). The present study 
indicated that aloesin possesses similar absorption pattern with 
aloe-emodin and also reaches physiological saturation levels at 
50 μM. The results also indicated that chromones form conjugates 
in the human small intestine by UDP-glucuronosyltransferase 
(UGT) (Vaidyanathan & Walle, 2002). Liu et al. (2007) indicated 
that well-expressed UGT isoforms in the Caco-2 cells, UGT1A1, 
UGT1A3, UGT1A6, and UGT2B7, were capable of metabolizing 
flavonoids. 
The absorption rate of aloesin were 7.61%, 13.64%, and 8.14% 
at 5, 10, and 50 μM, respectively, which were higher than those 
of either aloin or aloe-emodin, and the absorbed concentration 
was higher at 50 μM compared to either aloin or aloe-emodin. 
Free hydroxyl groups in flavonoids can hinder transport in 
Caco-2 cell monolayer (Tammela et al., 2004). Ollila et al. (2002) 
stated that polyhydroxylated chemicals show longer retention 
delays in membranes, and this is most likely due to 
hydrogen-bond formation between their hydroxyl groups and 
polar groups of the lipid molecules at the lipid/water interface. 
Aloin and aloe-emodin have two hydroxyl groups, while aloesin 
has one hydroxyl group in their structure. Therefore, hydroxyl 
group would be responsible for high absorption of aloesin. 
The everted gut sac experiment was conducted to compare the 
Caco-2 monolayer data. The absorption rate of both aloin and 
aloe-emodin were similar rate Caco-2 monolayer model data, 
while aloesin absorption percentage was significantly higher in 
the everted gut sac model. One of the functional differences 
between normal intestine and Caco-2 cells is its lack of 
expression of the cytochrome P450 and LPH (Paine & Fisher, 
2000). Moreover, Caco-2 cells do not always express appropriate 
amounts of transporters or enzymes, which may introduce bias. 
Therefore, the everted gut sac model may provide more useful 
in vitro bioavailability screening tool for many physiologically 
active herbal components. 
This study provided information on the intestinal absorption 
rate and possible absorption mechanisms of aloe components. 
These results may be used to establish adequate intake level of 
aloe supplements to reach effective plasma concentration. 
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